The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Ciongoli Gregory Austin | Director | Buy(P) | 53K | $9.36 | $500K |
| Aug 26, 2026 | Ciongoli Gregory Austin | Director | Buy(P) | 49K | $9.14 | $450K |
| Aug 25, 2026 | Ciongoli Gregory Austin | Director | Grant(A) | 70K | — | $0 |
| Aug 25, 2026 | Ciongoli Gregory Austin | Director | Grant(A) | 15K | — | $0 |
| Aug 1, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | Tax withholding(F) | 5K | $9.69 | $46K |
| Aug 1, 2026 | Pakola Steve | Chief Medical Officer | Tax withholding(F) | 7K | $9.69 | $72K |
| Jul 2, 2026 | Pakola Steve | Chief Medical Officer | Option exercise(M) | 2K | $7.86 | $17K |
| Jul 2, 2026 | Pakola Steve | Chief Medical Officer | Sell(S) | 2K | $13.64 | $29K |
| Jul 2, 2026 | Pakola Steve | Chief Medical Officer | Option exercise(M) | 2K | — | $0 |
| Jul 1, 2026 | Pakola Steve | Chief Medical Officer | Option exercise(M) | 37K | $7.86 | $289K |
| Jul 1, 2026 | Pakola Steve | Chief Medical Officer | Sell(S) | 37K | $12.86 | $472K |
| Jul 1, 2026 | Pakola Steve | Chief Medical Officer | Option exercise(M) | 37K | — | $0 |
| Jul 1, 2026 | Simpson Curran | Chief Executive Officer, Director | Tax withholding(F) | 7K | $13.09 | $89K |
| Jun 30, 2026 | Simpson Curran | Chief Executive Officer, Director | Grant(A) | 1K | $10.18 | $15K |
| Jun 29, 2026 | Pakola Steve | Chief Medical Officer | Sell(S) | 20K | $11.04 | $216K |
| May 29, 2026 | Tasse Daniel | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Bennett Jean | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Bennett Jean | Director | Grant(A) | 47K | — | $0 |
| May 29, 2026 | Mills Kenneth T. | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Fox Allan M. | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Fox Allan M. | Director | Grant(A) | 47K | — | $0 |
| May 29, 2026 | Glucksmann Alexandra | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Glucksmann Alexandra | Director | Grant(A) | 47K | — | $0 |
| May 29, 2026 | Karabelas Argeris N | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Karabelas Argeris N | Director | Grant(A) | 47K | — | $0 |
| May 29, 2026 | Stump David C | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Stump David C | Director | Grant(A) | 47K | — | $0 |
| May 29, 2026 | Migausky George V | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Migausky George V | Director | Grant(A) | 47K | — | $0 |
| May 29, 2026 | Mills Kenneth T. | Director | Grant(A) | 47K | — | $0 |
| May 29, 2026 | Tasse Daniel | Director | Grant(A) | 47K | — | $0 |
| May 29, 2026 | Zachary Jennifer | Director | Grant(A) | 10K | — | $0 |
| May 29, 2026 | Zachary Jennifer | Director | Grant(A) | 47K | — | $0 |
| May 11, 2026 | Pakola Steve | Chief Medical Officer | Sell(S) | 15K | $11.02 | $169K |
| Mar 10, 2026 | Pakola Steve | Chief Medical Officer | Sell(S) | 5K | $10.35 | $53K |
| Feb 1, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | Tax withholding(F) | 5K | $11.16 | $52K |
| Feb 1, 2026 | Pakola Steve | Chief Medical Officer | Tax withholding(F) | 5K | $11.16 | $59K |
| Jan 27, 2026 | Mills Kenneth T. | Director | Tax withholding(F) | 222K | $13.41 | $3.0M |
| Jan 27, 2026 | Mills Kenneth T. | Director | Option exercise(M) | 225K | $13.09 | $2.9M |
| Jan 27, 2026 | Mills Kenneth T. | Director | Option exercise(M) | 225K | — | $0 |
| Jan 6, 2026 | Simpson Curran | Chief Executive Officer, Director | Grant(A) | 145K | — | $0 |
| Jan 6, 2026 | Simpson Curran | Chief Executive Officer, Director | Grant(A) | 234K | — | $0 |
| Jan 6, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | Grant(A) | 74K | — | $0 |
| Jan 6, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | Grant(A) | 40K | — | $0 |
| Jan 6, 2026 | Pakola Steve | Chief Medical Officer | Grant(A) | 66K | — | $0 |
| Jan 6, 2026 | Pakola Steve | Chief Medical Officer | Grant(A) | 35K | — | $0 |
| Jan 6, 2026 | Chan Mitchell | Chief Financial Officer | Grant(A) | 74K | — | $0 |
| Jan 6, 2026 | Chan Mitchell | Chief Financial Officer | Grant(A) | 40K | — | $0 |
| Jan 6, 2026 | Malzahn Craig | Chief Technology Officer | Grant(A) | 66K | — | $0 |
| Jan 6, 2026 | Malzahn Craig | Chief Technology Officer | Grant(A) | 35K | — | $0 |
| Jan 2, 2026 | Simpson Curran | Chief Executive Officer, Director | Tax withholding(F) | 19K | $14.40 | $267K |
| Jan 2, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | Tax withholding(F) | 10K | $14.40 | $141K |
| Jan 2, 2026 | Pakola Steve | Chief Medical Officer | Tax withholding(F) | 18K | $14.40 | $263K |
| Jan 2, 2026 | Malzahn Craig | Chief Technology Officer | Tax withholding(F) | 1K | $14.40 | $18K |
| Dec 31, 2025 | Simpson Curran | Chief Executive Officer, Director | Grant(A) | 951 | $7.00 | $7K |
| Oct 9, 2025 | Simpson Curran | Chief Executive Officer, Director | Sell(S) | 21K | $12.62 | $263K |
| Sep 29, 2025 | Simpson Curran | Chief Executive Officer, Director | Sell(S) | 8K | $10.03 | $76K |
| Sep 10, 2025 | Simpson Curran | Chief Executive Officer, Director | Sell(S) | 8K | $10.02 | $77K |
| Sep 1, 2025 | Chan Mitchell | Chief Financial Officer | Tax withholding(F) | 5K | $8.93 | $44K |
| Sep 1, 2025 | Malzahn Craig | Chief Technology Officer | Tax withholding(F) | 234 | $8.93 | $2K |
| Aug 1, 2025 | Christmas Patrick J. | Chief Strategy & Legal Officer | Tax withholding(F) | 5K | $8.19 | $38K |
| Jul 1, 2025 | Simpson Curran | Chief Executive Officer, Director | Tax withholding(F) | 5K | $8.23 | $39K |
| May 30, 2025 | Bennett Jean | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Bennett Jean | Director | Grant(A) | 40K | — | $0 |
| May 30, 2025 | Karabelas Argeris N | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Karabelas Argeris N | Director | Grant(A) | 40K | — | $0 |
| May 30, 2025 | Glucksmann Alexandra | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Glucksmann Alexandra | Director | Grant(A) | 40K | — | $0 |
| May 30, 2025 | Migausky George V | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Migausky George V | Director | Grant(A) | 40K | — | $0 |
| May 30, 2025 | Mills Kenneth T. | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Mills Kenneth T. | Director | Grant(A) | 40K | — | $0 |
| May 30, 2025 | Stump David C | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Stump David C | Director | Grant(A) | 40K | — | $0 |
| May 30, 2025 | Tasse Daniel | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Tasse Daniel | Director | Grant(A) | 40K | — | $0 |
| May 30, 2025 | Zachary Jennifer | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Zachary Jennifer | Director | Grant(A) | 40K | — | $0 |
| May 30, 2025 | Fox Allan M. | Director | Grant(A) | 8K | — | $0 |
| May 30, 2025 | Fox Allan M. | Director | Grant(A) | 40K | — | $0 |
| May 12, 2025 | Mills Kenneth T. | Director | Option exercise(M) | 21K | $3.76 | $77K |
| May 12, 2025 | Mills Kenneth T. | Director | Sell(S) | 21K | $7.91 | $163K |
| May 12, 2025 | Mills Kenneth T. | Director | Option exercise(M) | 21K | — | $0 |
| Mar 27, 2025 | Mills Kenneth T. | Director | Option exercise(M) | 31K | $3.76 | $116K |
| Mar 27, 2025 | Mills Kenneth T. | Director | Option exercise(M) | 31K | — | $0 |
| Feb 1, 2025 | Danos Olivier | Chief Scientific Officer | Tax withholding(F) | 5K | $8.07 | $44K |
| Feb 1, 2025 | Pakola Steve | Chief Medical Officer | Tax withholding(F) | 5K | $8.07 | $42K |
| Feb 1, 2025 | Christmas Patrick J. | Chief Legal Officer | Tax withholding(F) | 5K | $8.07 | $38K |
| Jan 2, 2025 | Christmas Patrick J. | Chief Legal Officer | Tax withholding(F) | 11K | $7.73 | $88K |
| Jan 2, 2025 | Christmas Patrick J. | Chief Legal Officer | Grant(A) | 223K | — | $0 |
| Jan 2, 2025 | Chan Mitchell | Chief Financial Officer | Grant(A) | 63K | — | $0 |
| Jan 2, 2025 | Danos Olivier | Chief Scientific Officer | Grant(A) | 59K | — | $0 |
| Jan 2, 2025 | Danos Olivier | Chief Scientific Officer | Tax withholding(F) | 13K | $7.73 | $98K |
| Jan 2, 2025 | Danos Olivier | Chief Scientific Officer | Grant(A) | 96K | — | $0 |
| Jan 2, 2025 | Pakola Steve | Chief Medical Officer | Tax withholding(F) | 14K | $7.73 | $107K |
| Jan 2, 2025 | Pakola Steve | Chief Medical Officer | Grant(A) | 64K | — | $0 |
| Jan 2, 2025 | Pakola Steve | Chief Medical Officer | Grant(A) | 104K | — | $0 |
| Jan 2, 2025 | Simpson Curran | Chief Executive Officer, Director | Grant(A) | 479K | — | $0 |
| Oct 1, 2024 | Karabelas Argeris N | Director | Option exercise(M) | 10K | $3.76 | $38K |
| Oct 1, 2024 | Karabelas Argeris N | Director | Sell(S) | 10K | $10.11 | $101K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-08-28. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for RGNX